How did Ginkgo Bioworks' revenue and expenses trend in Q4 2024?

Ginkgo Bioworks' revenue and expenses in Q4 2024 showed a business-focused trend with significant revenue generation from cell engineering and biosecurity segments.

1. **Revenue Trend**:
- The company's total revenue for the quarter was $173.97 million, with a notable contribution from the cell engineering segment.
- The cell engineering segment alone generated $139.18 million, indicating its importance to the company's revenue stream.
- The biosecurity segment also contributed $53.07 million, with an additional $44.01 million from the service segment.
2. **Cost of Revenue and Operating Expenses**:
- The cost of goods sold was $9.62 million, representing a 6.35% increase from the previous period.
- The operating expenses for the quarter were $7.87 million, which, when combined with the cost of goods sold, highlights the company's focus on managing its operational costs alongside growing revenue.
3. **Segment Insights**:
- The cell engineering segment was the most revenue-generating, followed by the biosecurity and service segments.
- The consistent revenue from the cell engineering and biosecurity segments suggests Ginkgo Bioworks' strategic focus on these areas to drive growth.

Overall, Ginkgo Bioworks demonstrated a strong revenue trend in Q4 2024, with effective cost management supporting its business strategy.